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T hroughout medical history, unusual patient groups have often provided vital clues to the pathogenesis of disease. For example, the discovery of a small group of patients with a1proteinase inhibitor deficiency provided critical insights into the pathogenesis of emphysema. The study of hemophiliacs opened exciting new avenues of research and clinical intervention that are still being fruitfully explored. And chronic major-vessel thromboembolic pulmonary hypertension (C T-E PH) promises to be an instance in which a relatively small, unusual group of patients may provide much information about both thromboembolism and pulmonary vascular disease.
C T-E PH is the result of single or recurrent pulmonary emboli arising from sites of venous thrombosis. The natural history of most emboli is to undergo total resolution, or resolution leaving minimal residua, with restoration of normal pulmonary hemodynamics.1-5 For reasons still unclear, the emboli in C T-E PH patients do not resolve completely; rather, they follow an aberrant path of organization and recanalization, leaving endothelialized residua that obstruct or significantly narrow major (main, lobar, or segmental) pulmonary arteries.
From the reports of others6-1"2141 and our own experience with more than 250 C T-E PH patients, it is clear that there is a wide spectrum of residual embolic obstruction and therefore the degree to which pulmonary vascular resistance is increased. Some patients with chronic obstruction of one or more segmental or lobar arteries are nearly asymptomatic. At the other extreme are those who have major obstructions in multiple central pulmonary arteries and develop severe pulmonary hypertension and progressive right ventricular failure.
This disorder is quite distinct from so-called "primary" pulmonary hypertension in which the obstructing lesions appear in the small, distal pulmonary arteries. While in primary pulmonary hypertension there may be thrombotic lesions in these small arter-ies (which have been called "thromboembolic"), such patients also have nonthrombotic lesions. Most important, no embolic source can be identified.12 '13 The incidence of C T-E PH remains unknown. Earlier observations suggested that it was rare among patients who had suffered an acute pulmonary embolism.1-68'4 However, it has become apparent that the condition is more common than anticipated. For example, in 1983 we reported 15 patients operated on for this condition. '5 In 1984, Chitwood et a19 reviewed the world literature on C T-E PH patients who had undergone surgical correction and identified 85 patients. In 1986, Bengtsson et al10 reported three additional cases. By 1987, our own experience added an additional 27 patients to this list. 16 Rich et a18 described eight more patients with chronic proximal pulmonary thromboemboli in 1988. We have now evaluated more than 250 patients, of whom 195 have undergone a pulmonary thromboendarterectomy.
Undoubtedly, this accelerated recognition is in part due to surgical techniques that have made this condition a potentially remediable one; often, a detailed description of and availability of therapy for a previously hopeless condition catalyzes enhanced recognition.
Available data indicate that each year in the United States, approximately 600,000 individuals suffer a pulmonary embolic event."17 Approximately 150,000 of these patients die, leaving 450,000 patients a year as a potential denominator. If it is assumed that, for example, 0.01% of these patients have had massive emboli and fail to resolve them appropriately, then an accession rate of 450 patients a year with chronic thromboembolic pulmonary hypertension would be occurring. Whether this speculative estimate is too high or too low, only time and experience will demonstrate. Natural History The natural history of C T-E PH remains to be fully defined.1-6,8,18-21 However, experience with this patient population has delineated broad outlines of its clinical course. The majority of patients do have a history of venous thrombosis or pulmonary embolism. However, that history may not be elicited unless it is diligently sought. For example, most patients recall an episode of a "pulled muscle" in the leg or of a calf swelling that was attributed to local trauma, whereas few have had the diagnosis of deep venous thrombosis established by objective testing. Similarly, many patients recall an episode of unexplained dyspnea, "pneumonia," or "asthma"; a minority have had acute embolic disease diagnosed by scan or pulmonary angiography. Often, an episode of "myocardial infarction," unconfirmed by specific study, has occurred or a label of "nonspecific lung disease" has been applied.
Some patients have been briefly treated for pulmonary embolic disease, but few have been on long-term anticoagulant therapy. Others have had the diagnosis of primary pulmonary hypertension applied for months to years.
From reconstruction of the sequence of events in many of these patients, a natural history of C T-E PH emerges. After the initial embolic event, the patient improves. Dyspnea, which may have been severe at onset, gradually improves. If the patient was hospitalized for this episode, regardless of whether anticoagulation therapy was given, he or she usually returns to normal activities. However, patients become dyspneic at a lower level of exertion. This period of improvement is a "honeymoon" period during which the patient receives limited medical attention; if anticoagulants were administered, they are usually discontinued. Rarely have follow-up lung scans been performed.
With time, however, the patient notes increasing dyspnea on exertion. Sometimes the honeymoon lasts for several months; sometimes, for several years. But later, abruptly or gradually, deterioration of right ventricular function occurs. Hypoxemia often manifests during this period of progressive right ventricular failure.
While the pathogenetic basis of the honeymoon period and the reasons for its termination are not yet clearly defined, observations suggest that several events contribute to this sequence. During the initial phase, these patients develop right ventricular hypertrophy in response to significant elevation of pulmonary vascular resistance. With hypertrophy, they are able to maintain an adequate resting cardiac output and even achieve some augmentation of output during exercise. During time, however, additional changes in the pulmonary vascular bed may intervene. For example, preliminary observations from lung biopsy material indicate that these patients develop classic pulmonary hypertensive changes in the "open"-as well as in the obstructedpulmonary vascular bed. These pulmonary hypertensive changes further increase pulmonary vascular resistance and therefore right ventricular afterload. Alternatively, an increase in pulmonary vascular resistance may result from either embolic recurrence or in situ extension of chronic emboli. Available data indicate that embolic recurrence is relatively uncommon, even though this is a frequent clinical explanation for the patient's deterioration. When sequential even as the patient deteriorates. Proximal extension of pulmonary emboli, possibly promoted by turbulence due to downstream obstruction, is suggested by observations at thromboendarterectomy of reddish granulation tissue proximal to the obstructing white, organized thrombi. Such extensions can increase pulmonary vascular resistance further by reducing the available volume of the pulmonary vascular bed as well as by occluding previously unobstructed lobar or segmental orifices.
Finally, if the diagnosis is not established, the patient enters the phase of florid right ventricular failure. Hypoxemia becomes exaggerated by a combination of factors including a decline in cardiac output with a resultant fall in mixed venous Po2, worsening ventilation-perfusion relations,22 opening of the foramen ovale, and perhaps development of small pulmonary arteriovenous fistulas in the lung.
Thus, in summary, the natural history of C T-E PH is deceptive. The history of venous thrombosis and pulmonary embolism may be interpreted as reflecting other disorders. Even with embolism recognized, the honeymoon period may be taken as evidence that no significant embolic obstruction persists. And when overt right ventricular failure supervenes, other diagnoses, including primary pulmonary hypertension, are often made. Diagnosis The greatest advance regarding this condition has been increased recognition. While there are multiple diagnostic pitfalls to avoid, making the diagnosis is rather straightforward. The key is to consider C T-E PH in any patient with dyspnea on exertion for which no compelling cause can be found. The term "compelling" is important because certain other findings may suggest alternative diagnoses. For example, coronary artery disease is often believed to be present because C T-E PH patients have effort-induced chest pain due to right ventricular ischemia, and the electrocardiogram of severe right ventricular hypertrophy and strain may suggest an old anterior myocardial infarction.
Starting with the symptoms of effort dyspnea, historical clues compatible with a prior embolic event or venous thrombotic event should be sought. Study of the legs by noninvasive means (e.g., impedance plethysmography) may disclose findings compatible with chronic venous thrombosis. However, in many patients, the venous thrombotic event is sufficiently old that such testseven venographymay not confirm the diagnosis.
Physical examination may be deceptively normal, particularly before severe right ventricular dysfunction has developed. Until that occurs, of course, the jugular venous pulse may be unimpressive. Characteristically, the lung fields are clear to percussion and auscultation. However, there is one finding that should be sought, namely, a murmur (or murmurs) due to partial obstruction of the pulmonary arteries scans are available, they usually show little change, by thrombi.23These murmurs are heard over the lung fields rather than over the cardiac listening areas. They tend to be high pitched and continuous, frequently with respiratory augmentation. These are very similar to those heard in congenital branch stenosis of the pulmonary arteries or with pulmonary arteriovenous fistulas. Often, they are inaudible during breathing, buried in the breath sounds. They are best heard by having the patient hold his breath for short periods as each portion, front and back, of the lungs is examined. This is an important sign because such a murmur has not been reported in patients with primary pulmonary hypertension, an often-competing diagnosis.
The findings on cardiac examination are also conditioned by the degree of pulmonary hypertension and right ventricular dysfunction present. Early, the findings may be subtle, such as a soft right ventricular tap and mild accentuation of the pulmonary closure sound. Later, obvious findings such as a right ventricular heave, a palpable P2, fixed splitting of the second sound, a right ventricular S3, or striking tricuspid regurgitation may be present.
Again, depending on the stage of disease, the patient may have a negative abdominal examination or may show hepatomegaly, hepatic tenderness, or gross ascites. The lower extremities, likewise, may be edema free or quite edematous. Often, however, there is evidence of prior venous stasis involving one or both legs, chiefly hyperpigmentation of the malleolar areas characteristic of repetitive capillary ruptures due to high venous pressure.
The findings on standard laboratory studies depend heavily on the point in the natural history at which they are obtained. A chest radiograph usually demonstrates clear lung fields. However, close examination may disclose areas of hyperperfusion or hypoperfusion with enlargement or asymmetry in the caliber of the central pulmonary arteries. In some patients, striking bilateral enlargement of the pulmonary arteries has been misinterpreted as hilar adenopathy. In the most extreme form, a marked reduction in vascular size may suggest the presence of agenesis of one pulmonary artery. There may be evidence of old pleural disease, unilaterally or bilaterally. A minority of patients have had small cavitary lesions, apparently the sites of old infarcts that have excavated. The cardiac silhouette may reflect blatant right ventricular and right atrial enlargement; more often, right ventricular hypertrophy and enlargement are suggested only on the lateral film by encroachment on the normally empty retrosternal space.
Similarly, the electrocardiogram may be completely negative or it may show striking right-axis deviation, P pulmonale, or findings indicative of right ventricular hypertrophy and strain.
Routine hematologic and blood chemistry studies are usually unremarkable. Some patients do have increased hematocrits if they have been hypoxemic for some time. If special coagulation studies are done, most patients show no abnormalities. The most common abnormality has been the presence of a "lupus anticoagulant"; protein C, protein S, and antithrombin III deficiencies have occasionally been seen. Not surprisingly, then, a family history of thrombosis has been rare.
Pulmonary spirometric testing, which has been done primarily because the patients complain of effort dyspnea, is usually within normal limits. However, approximately 20% of the patients have had "restrictive" defects; that is, their vital capacity and total lung capacity are less than 80% of predicted. This finding has often led to the alternative diagnosis of interstitial lung disease. The basis for this restriction has not been defined. The majority of the patients do have a reduction in their single-breath diffusion capacity for carbon monoxide. Unfortunately, in a significant number, the CO transfer is at the lower edge of or in the normal range. Consequently, a normal CO transfer does not exclude the diagnosis of C T-E PH. Furthermore, the magnitude of reduction in the CO transfer does not reflect the severity of the vascular obstruction present.
Arterial blood gas studies at rest and with exercise are important elements in evaluation. Often, resting arterial Po2 is within normal limits, although the alveolar-arterial oxygen tension gradient is typically widened. Virtually all of the patients have a decline in arterial Po2 and a widening of the gradient during exercise. Frequently, this desaturation with exercise is the first objective finding in patients who present early in their course. Classic cardiac "stress tests," without measurement of the arterial blood gases (or 02 saturations by oximetry), usually yield negative results.
Another noninvasive test that is being used more frequently and is very helpful is echocardiography with Doppler evaluation. The diagnosis of pulmonary hypertension is often suggested by such studies. Enlargement of the right atrium or right ventricle, abnormal position and motion of the intraventricular septum, or estimation of the pulmonary artery systolic pressure by Doppler24 frequently were the first indications that a patient has significant right ventricular dysfunction or pulmonary hypertension.
The most direct test in suggesting the diagnosis of chronic thromboembolic disease has been the pulmonary perfusion scan. No patient has been reported, or seen by us, in whom the perfusion scan does not demonstrate at least one segmental or larger defect. Indeed, most often, several segmental or lobar defects are present bilaterally. Such a finding is in contrast to the perfusion scan in primary pulmonary hypertension, which is either normal or demonstrates patchy subsegmental abnormalities. 25, 26 It is usually the perfusion scan that puts the physician on the appropriate diagnostic path. However, even this study has diagnostic pitfalls; it has been a consistent finding that the perfusion scan underestimates the extent of proximal, chronic embolic obstruction.27 Furthermore, substantial but incomplete obstruction of major proximal arteries can occur without inducing a complete perfusion defect. Therefore, the finding of one or more perfusion defects that are segmental in size is compatible with severe thromboembolic pulmonary hypertension that may be subject to surgical correction. This caution is noteworthy because in many cases, physicians have felt that the patient could not have severe pulmonary hypertension on the basis of embolism because the scan is "relatively unimpressive." The perfusion scan should be complemented by a ventilation study. In these patients, the ventilation scan is normal, leading to the classic pattern of ventilation perfusion "mismatch."
With the presumption of chronic thromboembolic occlusion, the next step is to rule out other confounding entities and to confirm the severity of pulmonary hypertension and the location of the chronic thrombi. The most frequent confounding diagnoses have been fibrosing mediastinitis,28-30 tumor invasion of major pulmonary arteries,31 33 and Takayasu's disease. 34 Fibrosing mediastinitis can be excluded by computed tomographic scanning of the chest and, if necessary, retrograde catheterization of the pulmonary veins through the left atrium. Exclusion of tumor is substantially more difficult and may require exploratory surgery for confirmation. Takayasu's disease is, of course, rather uncommon. The finding of classic aortic or other arterial lesions indicates that the pulmonary arterial lesions are not caused by thrombi.
Right heart catheterization is necessary to define the severity of pulmonary hypertension and to exclude the possibilities of left-to-right shunting or "postcapillary" pulmonary hypertension. We have found it useful to have the patients exercise to augment cardiac output during catheterization; this provides some insight into whether the pulmonary vascular resistance is fixed. In addition, the absence of a substantial rise in pulmonary capillary wedge pressure during exercise provides some assurance that significant left heart dysfunction is not present. Although right heart catheterization can establish the presence of precapillary pulmonary hypertension, the exact cause of this problem is best determined with pulmonary angiography; this not only establishes the diagnosis but also, in the setting of chronic thrombi, determines whether these thrombi are accessible by surgery.
There have been two common problems with performing pulmonary angiography in pulmonary hypertensive patients. One universal concern is safety, and the other is difficulty in interpretation. With respect to safety, experience has indicated that pulmonary angiography can be safely performed, even in a patient with severe pulmonary hypertension; this has been reported by participants in the National Heart, Lung, and Blood Institute's Primary Pulmonary Hypertension Registry35 as well as by others.78, 36 We have followed a rather rigorous protocol to maximize safety,37 including catheterization via arm or neck (not via the femoral vein, a potential site of thrombus), a single injection of nonionic contrast median into the right and left main pulmonary arteries only, administration of oxygen during the procedure, and review of the large film angiograms after each injection before moving the catheter. Our interest focuses on the anatomical configuration of the main, lobar, and segmental branches in these patients. Repetitive injections and magnification views are avoided because they do not assist in deciding whether the thrombi are surgically accessible.
The interpretation of the pulmonary angiogram in patients with C T-E PH presents substantial difficulties, primarily because there are many patterns of organization and recanalization. The changes diagnostic of these chronic residuals do not resemble those relied on for the diagnosis of acute embolism. For example, filling defects and abrupt cutoffscharacteristic of acute embolism-are rarely seen. Interpretative capabilities regarding angiography have developed from repetitive comparison of angiographic findings with what is found at surgery. As this experience has expanded, many characteristic abnormalities in pulmonary vascular contour have been recognized that indicate the presence of chronic thrombi, including previously described webs and bands,38 pouchlike endings of arteries, irregularities in the arterial wall, and unusual proximal stenotic lesions. 39 While the pulmonary angiogram usually completes the diagnostic sequence in these patients, other studies are occasionally indicated. For example, left heart catheterization may be indicated to establish that left ventricular and left atrial pressures are normal and to rule out other coincident diagnoses. Coronary angiography is routinely performed on all patients more than 35 years old and occasionally in younger patients who have significant coronary risk factors. Finally, pulmonary angioscopy40 is performed in patients if the pulmonary angiographic findings do not precisely define thrombus location. This procedure, which allows direct visualization of the pulmonary vascular bed, has been of significant assistance in defining the site at which the chronic thrombotic material begins (i.e., in the main, lobar, or segmental branches). Whether other techniques, such as twodimensional echocardiography, intravascular Doppler imaging, ultrafast computed tomography, or magnetic resonance imaging, may aid in this determination remains to be determined.
Some have suggested that bronchial arteriography can determine operability by indicating whether distal pulmonary artery branches are open beyond proximal obstructions4' 42; this theory has not proved valid at our institution. Indeed, we have successfully operated on several patients who had been rejected elsewhere for thromboendarterectomy based on this theory. We therefore cannot recommend this procedure to assist in decision making.
Patient Selection for Pulmonary
Thromboendarterectomy Given the broad spectrum of this C T-E PH, it is clear that not all patients who have chronic thromboembolic obstruction require surgical correction. Selec-tion criteria continue to evolve with experience. At present, our major criteria are as follows. First, in general, patients who have a resting pulmonary vascular resistance ofat least 300 dynes * sec * cm-', or approximately 4 Wood units, merit consideration for surgery. Because effort dyspnea is the primary symptom of these patients, performance of exercise during catheterization is often informative. Modest elevations of pulmonary artery pressure at rest frequently become striking elevations as the patient attempts to augment cardiac output. Because this reproduces events during the patient's activities of daily living, this exercise may reflect the true work load of the right ventricle. Perhaps as information on the natural history of this disorder evolves, this arbitrary resting pulmonary vascular resistance criterion will prove too rigid.
The second criterion for potential surgical intervention is the accessibility of the thrombi as defined by angiography and angioscopy. Present surgical techniques allow removal of chronic thrombi residing in the main, lobar, and segmental arteries. Those that begin more distally may not be subject to endarterectomy. Because failure to remove obstruction is associated with a negative outcome, particularly in a patient with severe pulmonary hypertension and right ventricular dysfunction, this determination is critical.
The third criterion is the presence of collateral disease. The findings of renal disease, coronary artery disease, hematologic abnormalities, significant intrinsic lung disease, or cerebral vascular disease influence perioperative mortality and, of course, condition long-term functional outcome.
Finally, an important criterion is the willingness of the patient to accept the mortal and morbid risks of the corrective procedure. Patient and family cooperation and motivation are very important in the postoperative period.
Except for thrombus accessibility and the patient's expressed desire to undergo surgery, the other criteria are not absolute. For example, some patients who do not meet the pulmonary vascular resistance criterion have been operated on; the majority of these patients have one lung that is completely obstructed without involvement of the other. These patients have significant exertional dyspnea related to the very high alveolar dead space and the need to achieve extraordinary levels of minute ventilation during exercise. While such patients are rare, an effort to restore their pulmonary vascular bed to normal may be justified, particularly in the younger patient who is extremely limited by this large ventilatory requirement. The presence of collateral disease also is not an absolute contraindication. For example, the discovery of significant coronary artery disease may lead to the need for coronary artery bypass during the thromboendarterectomy procedure. However, the risks imposed by the presence of collateral diseases and their potential impact on long-term functional outcome should be carefully reviewed with the Surgical Approach In our view, it is important that before endarterectomy, the patient be protected against embolic occurrence from the lower extremities. Therefore, we routinely place a Greenfield filter4344 into the inferior vena cava before surgery unless an obvious nonleg or nonpelvic source of embolism is apparent.
(For example, in some patients, indwelling cardiac pacing wires or other chronic intravenous devices have been the embolic source.) The Greenfield filter is placed several days before surgery or, if it can be arranged, before the patient's arrival. Contrast venography to ensure that placement of the filter from a right or left femoral approach will not dislodge thrombi during filter placement is essential. If a femoral approach cannot be used, two options exist: one option is to place the filter from the internal jugular vein; the other option is to place the filter under direct observation through the right atrium during surgery. Others do not routinely protect such patients with a filter or other device7,8; long-term data regarding differential postoperative embolic recurrence rates among patients with and without such protection are not available at this time.
The thromboendarterectomy itself is a true endarterectomy; in no way does it resemble an acute embolectomy. Indeed, we are aware of several patients in whom some proximal reddish material has been removed from the pulmonary arteries during surgery without distal dissection. In these patients, there was no alteration in the lung scan or hemodynamic findings after surgery. The patient then faced the increased risk of reoperation to perform a true endarterectomy.
The surgical procedure, which allows maximum restoration of vascular patency, continues to evolve and improve.15,4546 All patients are approached by a median sternotomy rather than thoracotomy; in our opinion, the bronchial collateral flow through the pleura makes thoracotomy contraindicated. All patients are operated on during cardiopulmonary bypass; furthermore, hypothermia and periods of cardioplegia are essential. The required meticulous dissection necessitates a bloodless field, and without these maneuvers, adequate visualization-particularly in lobar and segmental branches-is not possible. Special precautions are taken to ensure adequate cardiac cooling while avoiding hypothermic injury to the phrenic nerves. Details of the current surgical approach have been described elsewhere.46 Direct observation of several endarterectomies best serves those who plan to undertake this procedure.
It should be emphasized that patients with pulmonary hypertension have bilateral vascular obstruction. Therefore, unilateral procedures are inadequate. Furthermore, most of the chronic thrombi are white and glistening components of the pulmonary arterial wall; there are no "red thrombi." Therefore, on opening heavily involved arteries, the obstructing lesions can patient before making a surgical decision. easily be overlooked. As a component of the arterial wall, they must be dissected carefully from the native wall to restore pulmonary arterial patency.
For several reasons, it should be noted that chronic pulmonary thrombi are not subject to treatment by angioplasty. First, they often completely obstruct arteries so that this technique is impossible. Second, the thrombi are of a fibrous consistency and tend to "4spring back" into their original configuration, even if subjected to significant compression. Finally, these fibrous masses are not subject to dissolution by thrombolytic agents.
Postoperative Course
The postoperative course in these patients presents complex and difficult management issues. First, these patients are, of course, subject to all of the complications common to all forms of cardiac surgery-bleeding, cardiac arrhythmias, infection, pericarditis, or pericardial effusions. Second, there is a unique possible complication, namely, acute reperfusion edema of the lungs.47 While this entity is an object of ongoing investigation, present data indicate that it represents a form of acute lung injury (adult respiratory distress syndrome). Its unique feature is that it is limited radiographically to those areas of the lung from which proximal vascular obstructions have been removed. It may appear at any time, from the immediate postoperative period (i.e., as the patient resumes his or her own circulation) to 72 hours after surgery. It is highly variable in severity, ranging from an acute, hemorrhagic, and fatal complication to a rather mild form of edema that poses the risk of only mild hypoxemia. And pulmonary perfusion continues through these edematous areas as demonstrated by scan, thereby causing a substantial amount of "low ventilation-perfusion'" zones with resultant hypoxemia. Thus, careful management of the patient, including mechanical ventilation, is essential.
Outcome
Several issues regarding shortand long-term outcomes are currently undergoing analysis. One concerns operative mortality; our overall operative and perioperative (in-hospital) mortality rate from the procedure has approximated 13%. Multivariate analyses of all of the potential risk factors as assessed preoperatively is incomplete at this time; however, certain trends conditioning mortality are apparent. Patients who are in New York Heart Association (NYHA) functional class IV have the highest risk of death. However, because these patients are rarely dyspneic at rest, our class IV category varies slightly from the NYHA criteria and includes individuals who with minimal activities of daily living develop marked dyspnea (e.g., walking to the hospital bathroom, walking a few steps within the room, taking a shower, and so on). Because the majority of our patients are in class IV at the time of referral, this obviously impacts the present overall mortality statistics. Other factors that appear to significantly increase the risk of death are age of more than 70 years, marked obesity, severity of the preoperative elevation of pulmonary vascular resistance, presence of very high right atrial pressures indicating severe right ventricular failure, perhaps duration of pulmonary hypertension, and presence of significant collateral disease, particularly of the kidney and the coronary arterial system.
Among survivors, hemodynamic and functional improvements have been striking. The immediate hemodynamic changes after thromboendarterectomy are given in Table 1 . The values reflect the preoperative cardiac catheterization data compared with data obtained just before removal of monitoring devices in the intensive care unit. These hemodynamic changes are also reflected in the sequential echocardiographic changes that disclose reduction in right atrial and right ventricular size, return of the interventricular septum to normal position with loss of paradoxical motion, and improvement in or resolution of tricuspid regurgitation; these findings have been reported elsewhere.48.49 On auscultation during the postoperative period, such changes are reflected by loss of the right ventricular tap or lift, return of normal inspiratory splitting of S2, resolution of an S3 (if present), or loss or diminution of the tricuspid regurgitant murmur. In addition, if marked jugular venous distention, hepatomegaly, or ascites with peripheral edema were present, there is resolution. In functional terms, the patients significantly improve by the time of discharge, which is approximately 2 weeks after surgery. This functional improvement continues for periods as long as 9-12 months after discharge; we speculate that this longer-term improvement reflects such factors as resolution of the postoperative edema, anemia, and deconditioned state. In addition, preliminary scan and angiographic data suggest that resolution of pulmonary hypertensive changes within the pulmonary vascular bed, thereby reducing right ventricular afterload, also adds to this long-term improvement. About one half of the patients require supplementary oxygen at the time of discharge (at least during exertion) to main- Thirty-four of our patients have returned for extensive postoperative evaluation by cardiac catheterization and angiography, either at our institution or at the institution of referral, months to years after surgery. Their resting hemodynamic data are presented in Table 2 . In addition, the angiographic follow-up has been informative. In the vast majority of patients, the follow-up angiogram is either normal or shows minimal residual distal obstruction in one or more segmental arteries. So far, there has been only one patient in whom postoperative scans and angiograms failed to show significant restoration of vascular patency. This patient had a unilateral chronic thromboembolic obstruction that had been present for some years. She rethrombosed both immediately after endarterectomy and after a second endarterectomy despite treatment with thrombolytic agents. The pathogenesis of this rethrombosis is unclear, although her lung biopsy indicated the presence of significant downstream hypertensive lesions, similar to those observed in an animal model of chronic pulmonary artery ligation. 50 The change in functional class of the first 79 patients on whom 1-year follow-up information is available is presented in Table 3 ; most of them have resumed normal activities.
To date, there have been no recurrences of pulmonary embolism or thrombosis in any patient, and our follow-up periods now extend as long as 18 years. As noted, virtually all patients have a Greenfield filter in place and are maintained on permanent warfarin therapy. There have been two instances of venous thrombosis recurrence, both in patients in whom anticoagulant therapy was interrupted; there have been no instances of thrombosis of the Green- Follow-up is 1 or more years after thromboendarterectomy.
The Future Like most experiments with nature, this one has raised more questions than it has answered. One thing seems clear, namely, an appropriately performed pulmonary thromboendarterectomy is much preferable to the only alternative (i.e., lung transplantation) because the immediate mortality rate is substantially lower and the patients have excellent long-term outcomes without the requirement of any immunosuppressive regimens. Also clear is that if the diagnosis can be made before class IV status intervenes, the mortality rate should be significantly reduced. Therefore, intervention before the "honeymoon" is over should decrease risk.
But the list of unanswered questions remains quite substantial. Among the issues meriting investigation are the following. First, what are the factors that determine the duration of the honeymoon? Preliminary data indicate that pulmonary hypertensive changes develop in the open and obstructed bed of these patients and of their animal counterparts,50,51 but the factors that condition the rate and extent of such changes remain uncertain. The pathogenesis of the troublesome reperfusion edema requires definition. Preliminary data indicate that this is a variant of acute respiratory distress syndrome with participation by oxidants and proteolytic enzymes. 52 We hope such studies will lead to preventive measures that may have applicability to other forms of acute lung injury.
The striking ability of a severely dysfunctional right ventricle with marked tricuspid insufficiency to return to a state of normal function has also been illuminating. Such observations have suggested that patients with severe pulmonary hypertension of other types who have been diagnosed as needing heart-lung transplantation may be well served by unilateral lung transplantation because their stressed right ventricles have the capacity to resume adequate function.
The list of investigative opportunities presented by this entity is substantial. However, perhaps the most intriguing issue is why these patients do not resolve their pulmonary emboli. One hypothesis is that these individuals have a fundamental defect in their thrombolytic system, that is, they are not "thrombosis prone," but rather they are simply unable to adefield filter during postdischarge follow-up. quately resolve emboli once they have occurred.
Perhaps, as previous researchers have suggested, this represents an imbalance of the intrinsic fibrolytic system-either a failure of the pulmonary endothelial cell to elaborate adequate quantities of tissue plasminogen activator or the mobilization of excessive tissue plasmin activator inhibitor. 53 Thus, research on the entity of C T-E PH has opened many new vistas for patients and investigators. For patients, the surgical approach that has been developed has offered a potentially curative intervention in what was previously a hopeless situation. For investigators, many opportunities for study of pulmonary vascular behavior and right ventricular function have developed; perhaps further insight into the pathogenesis of thromboembolism will also occur.
